Active Ingredient History

  • Now
Pegaspargase, sold under the brand name Oncaspar, is a medication used in the treatment of acute lymphoblastic leukemia (ALL). Often it is used together with anthracycline, vincristine, and corticosteroids. Pegaspargase can be administered either via an intravenous infusion or a intramuscular injection.   Wikipedia

More Chemistry
  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Prescription Only
  • Delivery Methods: Parenteral
  • Pro Drug: No

Drug Pricing (per unit)

United States

$2764.3580 - $3664.1900
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

oncaspar | pegasparaginase | peg-asparaginase | pegaspargase | peg e. coli l-asparaginase | peg-l-asparaginase | peg/l-asparaginase | pegylated asparaginase | pegylated-asparaginase | pegylated l-asparaginase | pegylated-l-asparaginase | pegylated l-asparaginase erwinia chrysanthemi | polyehylene glycol-asparaginase | polyethyleneglycol-asparaginase


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue